BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 16301660)

  • 1. The impairment of CD8 responses limits the selection of escape mutations in acute hepatitis C virus infection.
    Urbani S; Amadei B; Cariani E; Fisicaro P; Orlandini A; Missale G; Ferrari C
    J Immunol; 2005 Dec; 175(11):7519-29. PubMed ID: 16301660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD8 epitope escape and reversion in acute HCV infection.
    Timm J; Lauer GM; Kavanagh DG; Sheridan I; Kim AY; Lucas M; Pillay T; Ouchi K; Reyor LL; Schulze zur Wiesch J; Gandhi RT; Chung RT; Bhardwaj N; Klenerman P; Walker BD; Allen TM
    J Exp Med; 2004 Dec; 200(12):1593-604. PubMed ID: 15611288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transmitted/Founder Viruses Rapidly Escape from CD8+ T Cell Responses in Acute Hepatitis C Virus Infection.
    Bull RA; Leung P; Gaudieri S; Deshpande P; Cameron B; Walker M; Chopra A; Lloyd AR; Luciani F
    J Virol; 2015 May; 89(10):5478-90. PubMed ID: 25740982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positive selection of cytotoxic T lymphocyte escape variants during acute hepatitis C virus infection.
    Guglietta S; Garbuglia AR; Pacciani V; Scottà C; Perrone MP; Laurenti L; Spada E; Mele A; Capobianchi MR; Taliani G; Folgori A; Vitelli A; Ruggeri L; Nicosia A; Piccolella E; Del Porto P
    Eur J Immunol; 2005 Sep; 35(9):2627-37. PubMed ID: 16114108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistent recognition of autologous virus by high-avidity CD8 T cells in chronic, progressive human immunodeficiency virus type 1 infection.
    Draenert R; Verrill CL; Tang Y; Allen TM; Wurcel AG; Boczanowski M; Lechner A; Kim AY; Suscovich T; Brown NV; Addo MM; Walker BD
    J Virol; 2004 Jan; 78(2):630-41. PubMed ID: 14694094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of viral selected mutations on T cell mediated immunity in chronically evolving and self limiting acute HCV infection.
    Guglietta S; Garbuglia AR; Salichos L; Ruggeri L; Folgori A; Perrone MP; Camperio C; Mellace V; Maio G; Maio P; Capobianchi MR; Spada E; Gargano N; Scottà C; Piccolella E; Del Porto P
    Virology; 2009 Apr; 386(2):398-406. PubMed ID: 19232664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Escape from a dominant HLA-B*15-restricted CD8+ T cell response against hepatitis C virus requires compensatory mutations outside the epitope.
    Ruhl M; Chhatwal P; Strathmann H; Kuntzen T; Bankwitz D; Skibbe K; Walker A; Heinemann FM; Horn PA; Allen TM; Hoffmann D; Pietschmann T; Timm J
    J Virol; 2012 Jan; 86(2):991-1000. PubMed ID: 22072759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular immune selection with hepatitis C virus persistence in humans.
    Cox AL; Mosbruger T; Mao Q; Liu Z; Wang XH; Yang HC; Sidney J; Sette A; Pardoll D; Thomas DL; Ray SC
    J Exp Med; 2005 Jun; 201(11):1741-52. PubMed ID: 15939790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Virological and immunological determinants of intrahepatic virus-specific CD8+ T-cell failure in chronic hepatitis C virus infection.
    Neumann-Haefelin C; Timm J; Spangenberg HC; Wischniowski N; Nazarova N; Kersting N; Roggendorf M; Allen TM; Blum HE; Thimme R
    Hepatology; 2008 Jun; 47(6):1824-36. PubMed ID: 18454507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct Escape Pathway by Hepatitis C Virus Genotype 1a from a Dominant CD8+ T Cell Response by Selection of Altered Epitope Processing.
    Walker A; Skibbe K; Steinmann E; Pfaender S; Kuntzen T; Megger DA; Groten S; Sitek B; Lauer GM; Kim AY; Pietschmann T; Allen TM; Timm J
    J Virol; 2016 Jan; 90(1):33-42. PubMed ID: 26446603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutational escape from CD8+ T cell immunity: HCV evolution, from chimpanzees to man.
    Bowen DG; Walker CM
    J Exp Med; 2005 Jun; 201(11):1709-14. PubMed ID: 15939787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amino Acid Substitutions within HLA-B*27-Restricted T Cell Epitopes Prevent Recognition by Hepatitis Delta Virus-Specific CD8
    Karimzadeh H; Kiraithe MM; Kosinska AD; Glaser M; Fiedler M; Oberhardt V; Salimi Alizei E; Hofmann M; Mok JY; Nguyen M; van Esch WJE; Budeus B; Grabowski J; Homs M; Olivero A; Keyvani H; Rodríguez-Frías F; Tabernero D; Buti M; Heinold A; Alavian SM; Bauer T; Schulze Zur Wiesch J; Raziorrouh B; Hoffmann D; Smedile A; Rizzetto M; Wedemeyer H; Timm J; Antes I; Neumann-Haefelin C; Protzer U; Roggendorf M
    J Virol; 2018 Jul; 92(13):. PubMed ID: 29669837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selection of high-avidity CD8 T cells correlates with control of hepatitis C virus infection.
    Neveu B; Debeaupuis E; Echasserieau K; le Moullac-Vaidye B; Gassin M; Jegou L; Decalf J; Albert M; Ferry N; Gournay J; Houssaint E; Bonneville M; Saulquin X
    Hepatology; 2008 Sep; 48(3):713-22. PubMed ID: 18712791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Viral sequence evolution in acute hepatitis C virus infection.
    Kuntzen T; Timm J; Berical A; Lewis-Ximenez LL; Jones A; Nolan B; Schulze zur Wiesch J; Li B; Schneidewind A; Kim AY; Chung RT; Lauer GM; Allen TM
    J Virol; 2007 Nov; 81(21):11658-68. PubMed ID: 17699568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic variability of hepatitis C virus non-structural protein 3 and virus-specific CD8+ response in patients with chronic hepatitis C.
    López-Labrador FX; He XS; Berenguer M; Cheung RC; González-Candelas F; Wright TL; Greenberg HB
    J Med Virol; 2004 Apr; 72(4):575-85. PubMed ID: 14981760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-programmed death-1 levels on hepatitis C virus-specific T cells during acute infection are associated with viral persistence and require preservation of cognate antigen during chronic infection.
    Rutebemberwa A; Ray SC; Astemborski J; Levine J; Liu L; Dowd KA; Clute S; Wang C; Korman A; Sette A; Sidney J; Pardoll DM; Cox AL
    J Immunol; 2008 Dec; 181(12):8215-25. PubMed ID: 19050238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection.
    Wedemeyer H; He XS; Nascimbeni M; Davis AR; Greenberg HB; Hoofnagle JH; Liang TJ; Alter H; Rehermann B
    J Immunol; 2002 Sep; 169(6):3447-58. PubMed ID: 12218168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive analysis of CD8(+)-T-cell responses against hepatitis C virus reveals multiple unpredicted specificities.
    Lauer GM; Ouchi K; Chung RT; Nguyen TN; Day CL; Purkis DR; Reiser M; Kim AY; Lucas M; Klenerman P; Walker BD
    J Virol; 2002 Jun; 76(12):6104-13. PubMed ID: 12021343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative and functional differences in CD8+ lymphocyte responses in resolved acute and chronic hepatitis C virus infection.
    Lancaster T; Sanders E; Christie JM; Brooks C; Green S; Rosenberg WM
    J Viral Hepat; 2002 Jan; 9(1):18-28. PubMed ID: 11851899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dominant influence of an HLA-B27 restricted CD8+ T cell response in mediating HCV clearance and evolution.
    Neumann-Haefelin C; McKiernan S; Ward S; Viazov S; Spangenberg HC; Killinger T; Baumert TF; Nazarova N; Sheridan I; Pybus O; von Weizsäcker F; Roggendorf M; Kelleher D; Klenerman P; Blum HE; Thimme R
    Hepatology; 2006 Mar; 43(3):563-72. PubMed ID: 16496339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.